CEO of Beigene (30-Year Financial, Insider Trades) John Oyler (insider trades) sold 54,303 shares of BGNE on 09/29/2020 at an average price of $280.39 a share. The total sale was $15.2 million.
BeiGene Ltd is a biopharmaceutical company engaged in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. Its product includes BGB-3111, BGB-A317 and BGB-290 and one immuno-oncology agent. BeiGene Ltd has a market cap of $25.31 billion; its shares were traded at around $286.44 with and P/S ratio of 86.29. GuruFocus has detected 5 severe warning signs with BeiGene Ltd. .
CEO Recent Trades:
- CEO John Oyler sold 54,303 shares of BGNE stock on 09/29/2020 at the average price of $280.39. The price of the stock has increased by 2.16% since.
- CEO John Oyler sold 81,228 shares of BGNE stock on 09/16/2020 at the average price of $253.46. The price of the stock has increased by 13.01% since.
- CEO John Oyler sold 61,042 shares of BGNE stock on 09/02/2020 at the average price of $233.21. The price of the stock has increased by 22.82% since.
CFO Recent Trades:
- CFO & Chief Strategy Officer Howard Liang sold 14,000 shares of BGNE stock on 09/14/2020 at the average price of $250.27. The price of the stock has increased by 14.45% since.
Directors and Officers Recent Trades:
- Chair, Scientific Advisory Brd Xiaodong Wang sold 5,000 shares of BGNE stock on 09/25/2020 at the average price of $280.42. The price of the stock has increased by 2.15% since.
- President & GM China Xiaobin Wu sold 4,000 shares of BGNE stock on 09/25/2020 at the average price of $280.35. The price of the stock has increased by 2.17% since.
- Chair, Scientific Advisory Brd Xiaodong Wang sold 5,000 shares of BGNE stock on 09/17/2020 at the average price of $260.27. The price of the stock has increased by 10.05% since.
- President & GM China Xiaobin Wu sold 4,000 shares of BGNE stock on 09/17/2020 at the average price of $260.33. The price of the stock has increased by 10.03% since.
- CMO, Hematology Jane Huang sold 3,128 shares of BGNE stock on 09/03/2020 at the average price of $233.07. The price of the stock has increased by 22.9% since.
For the complete insider trading history of BGNE, click here
.- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
